REG - Partners Grp Pvt Eqt Partners Grp E-PEYS - Sale of Clario

Partners Private EquityAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251103:nRSC7464Fa&default-theme=true

RNS Number : 7464F  Partners Group Private Equity Ltd  03 November 2025

(LSE: PEY/PEYS)

 

Partners Group Private Equity Limited

 

Sale of Clario

 

 

Partners Group Private Equity Limited ("PGPE Ltd" or "the Company") today
announces the sale of Clario, an industry leading provider of data collection
and analysis solutions to drug developers, to Thermo Fisher Scientific.

 

·    As of 31 August 2025, Clario is the eighth-largest investee company
in the portfolio of PGPE Ltd at approximately EUR 27.5 million

·    The transaction values the stake of PGPE Ltd in Clario in line with
the latest published NAV

·    PGPE Ltd first invested in eResearch Technology ("ERT") in 2020,
alongside other investors. In 2021, the Company participated in a follow-on
investment to support ERT's merger with BioClinica, resulting in the formation
of Clario. The total amount invested by PGPE Ltd is EUR 13.5 million

·    The transaction is subject to customary regulatory approvals and is
expected to close by the end of Q2 2026

 

Headquartered in Philadelphia, Clario is an industry leading provider of data
collection and analysis solutions to drug developers. Clario's technology
platform has powered more than 30,000 clinical trials and supported 70% of FDA
and EMA new drug approvals over the past decade. Combining nearly 50 years of
technological and scientific expertise at global scale, Clario enables
pharmaceutical, biotech, and medical device companies to accelerate innovation
and improve patient outcomes.

 

 

 

Ends.

 

About Partners Group Private Equity Limited

PGPE Ltd is an investment holding company founded in 1999 and domiciled in
Guernsey. It invests in private equity direct investments. PGPE Ltd is managed
in its investment activities by Partners Group, a global private markets
investment management firm with over USD 174 billion in investment programs
under management in private markets, of which USD 83 billion is in private
equity. Partners Group itself is listed on the Swiss Stock Exchange (ticker:
PGHN). PGPE Ltd aims to provide shareholders with long-term capital growth and
an attractive dividend yield. PGPE Ltd is traded on the Main Market of the
London Stock Exchange (ticker: PEY for the Euro quote; PEYS for the Sterling
quote).

 

 

Contacts

Partners Group Private Equity Limited:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

 

 Investor relations contact:                  Media relations contact:

 Andreea Mateescu                             Jenny Blinch

 Phone: +41 41 784 66 73                      Phone: +41 41 784 65 26

 E-mail: andreea.mateescu@partnersgroup.com   E-mail: jenny.blinch@partnersgroup.com

 

Registered Number: 35241   LEI: 54930038LU8RDPFFVJ57

Notes:

1.    Note that references in this announcement to Partners Group Private
Equity Limited have been abbreviated to "PGPE Ltd" or "the Company".
References to Partners Group AG have been abbreviated to "Partners Group" or
"the Investment Manager".

2.    This document does not constitute an offer to sell or a solicitation
of an offer to buy or subscribe for any securities and neither is it intended
to be an investment advertisement or sales instrument of Partners Group
Private Equity Limited. The distribution of this document may be restricted by
law in certain jurisdictions. Persons into whose possession this document
comes must inform themselves about and observe any such restrictions on the
distribution of this document. In particular, this document and the
information contained therein are not for distribution or publication, neither
directly nor indirectly, in or into the United States of America, Canada,
Australia or Japan.

3.   This document may have been prepared using financial information
contained in the books and records of the product described herein as of the
reporting date. This information is believed to be accurate but has not been
audited by any third party. This document may describe past performance, which
may not be indicative of future results. No liability is accepted for any
actions taken on the basis of the information provided in this document.
Neither the contents of PGPE Ltd's website nor the contents of any website
accessible from hyperlinks on PGPE Ltd's website (or any other website) are
incorporated into, or form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DISZFLFXEBLBFBZ



            Copyright 2019 Regulatory News Service, all rights reserved